About Macro Array Diagnostics
Macro Array Diagnostics is a Healthcare company based in Kyiv (Ukraine) founded in 2016. It operates as an allergen analyzers are provided for in-vitro IgE level determination. Its focus areas include Life Sciences, Immunology, In Vitro Diagnostic Tests and Allergies. Its competitors include Allergy Amulet, YorkTest, ATANIS Biotech, DST and Microtest Diagnostics and 2 more; 3 of its 7 listed competitors have raised funding.
Company details
Macro Array Diagnostics was founded in 2016 in Kiev, Ukraine, and operates in the medical diagnostics sector. Allergen analyzers are supplied, with the ALEX platform as the primary tool for in-vitro analysis. Levels of total IgE and specific IgE are measured in blood to identify allergenic molecules and extracts. The approach relies on nanotechnologies, supporting allergy diagnostics through the companys domain, macroarraydx.com.ua.
- Headquarters Kyiv, Ukraine
- SectorsHealthcare
- Phone•••• ••••
- Website macroarraydx.com.ua
- Latest Funding Round$55.5K (USD), Grant
May 2020
- Investors
Funding Insights of Macro Array Diagnostics
- Total Rounds 1
- Last Round Grant — $55,502
- First Round $55,502
(May 2020)
- Investors Count 1
All 1 funding rounds of Macro Array Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | $55,502 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Macro Array Diagnostics
Macro Array Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium |
Investor details for Macro Array Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Macro Array Diagnostics
2 dated milestones of Macro Array Diagnostics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Macro Array Diagnostics is founded.
- Funding First funding round of $56K.
Competitors of Macro Array Diagnostics
Macro Array Diagnostics has 7 listed competitors in our database, 3 of them funded. They include Allergy Amulet, YorkTest, ATANIS Biotech, DST and Microtest Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allergyamulet.com | 2016 | Madison, United States | $12.57M | – | Portable food allergen sensors are offered via an online platform. | |
| yorktest.com | 1982 | York, United Kingdom | $12.03M | 38 | At-home food and allergy test kits are developed by YorkTest. | |
| atanis-biotech.com | 2021 | Sursee, Switzerland | – | – | Developer of a cell-based assay for the diagnosis of allergies | |
| dst-diagnostic.com | 2005 | Schwerin, Germany | – | 42 | Innovative in-vitro diagnostic solutions are developed by DST. | |
| microtestdx.com | 2002 | London, United Kingdom | $2.5M | 6 | Functions as an automated allergy testing service. | |
| allergenis.com | 2017 | Hatfield, United States | – | – | Develops accurate allergy testing solutions for healthcare providers and patients. | |
| immunovent.com | 2012 | New York, United States | – | – | Diagnostic tests for allergies are developed using mucosal brush samples. |
Detailed competitors of Macro Array Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Macro Array Diagnostics
The website of Macro Array Diagnostics (macroarraydx.com.ua) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 8.1% vs previous month
Websites whose visitors overlap most with Macro Array Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
allergolog-centr.com.ua | allergolog-centr.com.ua | 100% | – | #7,453,122 | – |
synevo.ge | synevo.ge | 79% | – | #283,370 | – |
allergo.kiev.ua | allergo.kiev.ua | 65% | – | #4,286,024 | – |
Top companies in Immunology & Cancer Therapeutics
10 companies that operate in the same segment as Macro Array Diagnostics (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Macro Array Diagnostics
Macro Array Diagnostics was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Macro Array Diagnostics is headquartered in Kyiv, Ukraine.
Macro Array Diagnostics was founded in 2016 in Kiev, Ukraine, and operates in the medical diagnostics sector. Allergen analyzers are supplied, with the ALEX platform as the primary tool for in-vitro analysis. Levels of total IgE and specific IgE are measured in blood to identify allergenic molecules and extracts. The approach relies on nanotechnologies, supporting allergy diagnostics through the companys domain, macroarraydx.com.ua.
Macro Array Diagnostics's top competitors include Allergy Amulet, ATANIS Biotech and YorkTest.
Macro Array Diagnostics has 1 investor. Key investors include EIC Fund.